Articles by Anjan Selz

The Drive for Best Practice in Biopharmaceutical Manufacturing

Key business considerations when developing biosimilar products virtually.
Mar 1, 2012
By: Anjan Selz

Key business considerations when developing biosimilar products virtually.

Biosimilar development in a virtual biotech set-up - Part I

Dec 5, 2011
By: Anjan Selz

How does working in a virtual biotech environment affect biosimilar development? Anjan Selz outlines target and partner selection in this first of a two part article.

Biosimilar Development in a Virtual Biotech Environment - Part II

Dec 5, 2011
By: Anjan Selz

Virtual biotech CEO Anjan Selz focuses on product development, credibility and differentiation.